Logo
DR.LIPO+ (10mL x 10 vials)

DR.LIPO+ (10mL x 10 vials)

Dr. Lipo+

Aesthetic Injectable – Lipolytic Solution
  • Manufactured in South Korea following local cosmetic/aesthetic product standards and export requirements; specific regulatory status may vary by country.
  • Use subject to local regulations governing injectable lipolytic agents and professional scope of practice.
Body Fat Dissolving Injection

Description

DR.LIPO+ is a new-generation injectable PPC (phosphatidylcholine) lipolysis solution designed for targeted body fat reduction and cellulite treatment. Each box contains 10 sterile vials of 10 mL, formulated with phosphatidylcholine, sodium deoxycholate and carnitine, along with supportive actives, to provide direct lipolytic action on adipocytes. By breaking down fat cells in the subcutaneous layer and transforming them into a liquid emulsion that is naturally eliminated via the lymphatic and metabolic systems, DR.LIPO+ delivers fast and long-lasting slimming and contouring effects in areas that are often resistant to diet and exercise. It is suitable for professional use on multiple body zones including abdomen, waist, hips, thighs, buttocks, back and upper arms, helping achieve a more sculpted silhouette without surgery.

Bnefits

  • New generation PPC lipolysis solution combining phosphatidylcholine, sodium deoxycholate and carnitine for enhanced fat-dissolving action. (cosmetix.eu, derma-solution.com, gosupps.com)
  • Directly targets adipocytes, causing fat cell lysis and emulsification, with natural elimination through the body’s metabolic processes. (cosmetix.eu, derma-solution.com)
  • Provides fast and long-lasting results in reduction of localised fat and visible cellulite. (derma-solution.com, gosupps.com)
  • Helps reshape and contour body areas that are difficult to slim with diet and exercise alone, such as abdomen, hips, thighs and arms. (derma-solution.com)
  • Supports skin tightening and improved tissue tone in treated areas, contributing to smoother contours. (gosupps.com)
  • Suitable for a wide range of treatment areas for both women and men, offering a versatile non-surgical body-contouring option. (derma-solution.com)
  • Ready-to-use solution in 10 mL vials, convenient for professional in-clinic protocols.
  • Part of a recognised Korean lipolytic portfolio with strong market adoption and positive practitioner feedback.

Indications

  • Localised subcutaneous fat deposits on the body (e.g. abdomen, waist, flanks, hips, thighs, buttocks, upper arms, back). (derma-solution.com, gosupps.com)
  • Fibrous cellulite and uneven fat pads resistant to diet and exercise. (derma-solution.com)
  • Body contouring and circumferential reduction in specific areas (e.g. love handles, saddlebags, inner thighs).
  • Patients seeking non-surgical fat reduction and body sculpting where small-to-moderate localised fat is present and skin elasticity is relatively preserved.
  • Adjunct treatment in broader weight-management or body-contouring programmes when appropriate and supervised by a trained professional.

Composition

  • Water
  • Phosphatidylcholine (PPC)
  • Sodium Deoxycholate (Deoxycholic Acid)
  • Carnitine
  • SP1-EGF (Epidermal Growth Factor)
  • SP1-FGF1 (Fibroblast Growth Factor 1)
  • Optional additional peptides and excipients as listed in manufacturer’s detailed formula (e.g. Acetyl Hexapeptide-8, Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Nicotinoyl Tripeptide-1, 1,2-Hexanediol – as confirmed for Dr. Lipo+ Body on Derma Solution). (derma-solution.com, koreafillerexperts.com)

Formulation

  • Sterile, ready-to-use injectable lipolytic solution.
  • Active base: PPC + sodium deoxycholate + carnitine, with growth factors and peptides in aqueous solution.
  • Volume per vial: 10 mL.
  • Presentation: 10 mL x 10 vials per box (total 100 mL). (derma-solution.com, koreafillerexperts.com)
  • Intended for subcutaneous injection into localised fat deposits on the body.
  • Non-pyrogenic, single-use vials designed for professional use.

Packaging

  • Outer carton containing 10 glass vials, each with 10 mL of DR.LIPO+ solution.
  • Each vial closed with rubber stopper and aluminium/plastic flip-off cap to maintain sterility.
  • Carton labelled with product name (DR.LIPO+), volume (10 mL x 10 vials), batch number, expiry date, manufacturer (BNC Global) and basic usage information.
  • Package insert/Instructions for Use for healthcare professionals, outlining indications, composition and recommended protocol.

Usage

  • For professional use only – must be administered by licensed medical professionals or trained practitioners in accordance with local regulations.
  • Assess the patient’s medical history, indications and treatment goals; mark the target areas on the body.
  • Clean and disinfect the treatment area thoroughly using appropriate antiseptic solutions.
  • Using a suitable syringe and fine needle (commonly 27G–30G, depending on protocol), inject small aliquots (e.g. 0.1–0.2 mL per point) into the subcutaneous fat layer at a depth appropriate to the site; avoid intradermal or intramuscular injection. (derma-solution.com)
  • Space injection points approximately 1–2 cm apart across the treatment area to achieve even product distribution.
  • Do not exceed the maximum recommended total volume per session and per area as specified in the product instructions and clinical protocols.
  • A typical course may involve around 10 treatment sessions spaced at about 14-day intervals, adjusted according to the amount of fat, area size and patient response. (derma-solution.com)
  • After injection, gentle massage of the area may be used according to protocol to help distribute the product.
  • Provide post-treatment guidance: advise the patient to maintain good hydration, avoid alcohol and intense physical activity and to follow any clinic-specific aftercare instructions during the initial 24–48 hours.
  • Dispose of all used materials (needles, syringes, vials) in designated sharps containers and clinical waste according to local regulations.

Contraindications

  • Known hypersensitivity or allergy to phosphatidylcholine, sodium deoxycholate, carnitine, growth factors, peptides or any excipients in the formulation.
  • Active skin or soft tissue infections, inflammation, dermatitis or open wounds at or near the target injection site.
  • Severe systemic illness, uncontrolled diabetes, significant hepatic or renal impairment or other conditions that may compromise fat metabolism or wound healing, unless cleared by a physician.
  • Bleeding disorders or current use of anticoagulant or antiplatelet therapy where increased risk of bruising or haematoma is deemed unacceptable.
  • History of severe allergic reactions or anaphylaxis to injectable aesthetic products.
  • Pregnancy or breastfeeding, due to lack of safety data.
  • Patients under 18 years of age.
  • Autoimmune diseases or immunosuppressive therapy, unless assessed and approved by a physician.
  • Avoid injection into or near major vessels, nerves, varicose veins or areas with compromised circulation or severe scarring.

Adverse Effects

  • Common transient injection-site reactions: pain, burning or stinging, erythema, swelling, warmth, tenderness and bruising.
  • Temporary nodules or induration in the treated area as inflammatory response and fat breakdown occur, generally resolving over days to weeks.
  • Localised oedema and discomfort, which may be more pronounced during the first few days following treatment.
  • Risk of infection at injection sites if aseptic technique and appropriate post-treatment care are not strictly followed.
  • Post-inflammatory hyperpigmentation or contour irregularities if product distribution is uneven or if treatment is overly aggressive.
  • Hypersensitivity reactions or allergy to one or more components, potentially requiring medical intervention.
  • Very rare but serious complications associated with injection procedures in general, such as tissue necrosis, abscess formation or nerve injury, especially if injected too superficially, too deeply or in contraindicated areas.

Storage Conditions

  • Store at controlled room temperature according to manufacturer’s specification (commonly between 2 °C and 25 °C).
  • Protect from direct sunlight, excessive heat and freezing.
  • Keep vials in their original carton until use to protect from light and facilitate batch/expiry tracking.
  • Do not use after the expiry date printed on the vial and outer packaging.
  • Once a vial is opened and used for a treatment session, discard any remaining solution; do not reuse or resterilise.
  • Keep out of reach of children and unauthorised persons.

Duration

Treatment is delivered as a series of sessions, typically up to about 10 procedures with 14-day intervals, depending on the severity and distribution of fat deposits and individual response. Visible improvements usually accrue over weeks to months, and maintenance sessions may be considered based on outcomes and practitioner assessment. (derma-solution.com)

Onset

Early changes, such as mild reduction in localised fullness, may be observed within a few weeks after the first treatments as adipocytes undergo lysis and lipids are metabolised. More significant circumferential reduction and contour changes generally become evident after several sessions and continue to evolve over subsequent weeks as the body eliminates the emulsified fat. (derma-solution.com, gosupps.com)

Browse more Aesthetic Injectable \u2013 Lipolytic Solution

Top Treatments

Top Cities in the UK